ValiRx at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
ValiRx takes part in 2 sessions at Cell 2026 in London. Its sessions focus on closing the gap between lab models and the medicines they are meant to predict. The specific topic is using patient-derived cells as new approach methods for more predictive cancer models.
| Organization | Cell 2026 Attendance |
|---|---|
UK-listed oncology drug developer that evaluates and develops early assets; its Inaphaea BioLabs unit supplies patient-derived cancer cell models. | Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap Stem cells, organoids and cell models Talk Fri Nov 13 1:55pm–2:20pm Patient Derived Cells As New Approach Methodologies For More Predictive Oncology Models Stem cells, organoids and cell models |
Instantly find 20 buyers from ValiRx
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction